4
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10951 |
Dabigatran ethyl ester hydrochloride
N-[[2-[[[4-(氨基亚氨甲基)苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-N-(2-吡啶基)-BETA-丙氨酸乙酯盐酸盐 |
Others; Thrombin | Others; Proteases/Proteasome |
Dabigatran ethyl ester hydrochloride 是一种核糖基二氢烟酰胺脱氢酶抑制剂,IC50=0.8 μM,也是一种凝血酶的抑制剂。 | |||
T6798 |
Tretazicar
5-Aziridino-2,4-dinitrobenzamide,CB1954,NSC 115829 |
DNA Alkylator/Crosslinker; DNA Alkylation | DNA Damage/DNA Repair |
Tretazicar (NSC-115829) 是一种抗肿瘤前药,由 NAD(P)H 醌氧化还原酶 2 激活。它在酶促活化后生成细胞毒性双功能烷基剂,可以形成 DNA-DNA 链间交联。 | |||
T68942 |
Caricotamide
|
Others | Others |
Caricotamide is a synthetic co-substrate that activates the human endogenous enzyme NRH:quinone oxidoreductase 2 (NQO2) with potential chemoadjuvant activity. When caricotamide is administered simultaneously with the prodrug tretazicar, NQO2 converts tretazicar to the bifunctional alkylating agent dinitrobenzamide, which is capable of forming a high degree of DNA interstrand cross-links, resulting in the inhibition of DNA replication and the induction of apoptosis. NQO2 has been found to be over... | |||
T60402 |
Tubulin inhibitor 14
|
Others | Others |
Tubulin inhibitor 14 是一种有效的 NQO2(醌氧化还原酶 2)抑制剂,IC50 为 1.0 μM,也抑制微管蛋白聚合和内皮细胞毛细管样管的形成。Tubulin inhibitor 14 是一种微管去稳定剂,具有潜在的肿瘤选择性以及抗血管生成和血管破坏的功能[1]。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-02882 |
NQO2 Protein, Mouse, Recombinant (His)
Ribosyldihydronicotinamide dehydrogenase [quinone],Quinone r... |
Mouse | P. pastoris (Yeast) |
The enzyme apparently serves as a quinone reductase in connection with conjugation reactions of hydroquinones involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis. |